These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mephentermine dependence syndrome - A new emerging trend of substance use. Gowda GS; Singh A; Ravi M; Math SB Asian J Psychiatr; 2015 Oct; 17():101-2. PubMed ID: 26236018 [No Abstract] [Full Text] [Related]
43. [Obesity epidemic after Letigen]. von Eyben FE Ugeskr Laeger; 2002 Dec; 164(49):5820. PubMed ID: 12523231 [No Abstract] [Full Text] [Related]
44. [Psychiatric illness associated with amphetamines and other stimulants]. Fischer RB Psychiatr Prax; 2000 May; 27(4):203. PubMed ID: 17195515 [No Abstract] [Full Text] [Related]
45. Cocaine psychoses: a continuum model. Post RM Am J Psychiatry; 1975 Mar; 132(3):225-31. PubMed ID: 1115261 [TBL] [Abstract][Full Text] [Related]
46. Psychosis associated with modafinil and shift work. Mariani JJ; Hart CL Am J Psychiatry; 2005 Oct; 162(10):1983. PubMed ID: 16199854 [No Abstract] [Full Text] [Related]
48. Self-medication with pseudoephedrine in a chronically depressed patient. Diaz MA; Wise TN; Semchyshyn GO Am J Psychiatry; 1979 Sep; 136(9):1217-8. PubMed ID: 474820 [No Abstract] [Full Text] [Related]
49. A case of late-onset crack dependence and subsequent psychosis in the elderly. Nambudiri DE; Young RC J Subst Abuse Treat; 1991; 8(4):253-5. PubMed ID: 1787549 [TBL] [Abstract][Full Text] [Related]
51. Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol. Tormey WP; Bruzzi A Med Sci Law; 2001 Oct; 41(4):331-6. PubMed ID: 11693229 [TBL] [Abstract][Full Text] [Related]
52. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. McKetin R; Baker AL; Dawe S; Voce A; Lubman DI Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630 [TBL] [Abstract][Full Text] [Related]
54. Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone. Jacob MK; Ash P; Craighead WE Eur Child Adolesc Psychiatry; 2012 Mar; 21(3):165-8. PubMed ID: 22249643 [TBL] [Abstract][Full Text] [Related]
55. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS; Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244 [TBL] [Abstract][Full Text] [Related]
56. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms]. Rubner O; Kummerhoff PW; Haase H Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625 [TBL] [Abstract][Full Text] [Related]
57. Cholinesterase inhibitors might alleviate methamphetamine-induced delusions, hallucinations and cognitive impairment, while reducing craving and addiction. Alisky JM World J Biol Psychiatry; 2006; 7(4):269. PubMed ID: 17071550 [No Abstract] [Full Text] [Related]
58. [Cortisone-induced delusional depression in systemic lupus erythematosus]. Hatzinger M; Seifritz E; Hemmeter U; Holsboer-Trachsler E Psychiatr Prax; 1994 Sep; 21(5):199-203. PubMed ID: 7972564 [TBL] [Abstract][Full Text] [Related]
59. [Ephedrine and ephedra in weight loss products and other preparations]. van der Hooft CS; Stricker BH Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223 [TBL] [Abstract][Full Text] [Related]
60. Ephedrine-type alkaloid-containing dietary supplements and substance dependence. Miller SC; Waite C Psychosomatics; 2003; 44(6):508-11. PubMed ID: 14597686 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]